Eli Lilly is suing ten medical spas, wellness centres and compounding pharmacies to stop the “unlawful marketing” and sales of products fraudulently claiming to be Mounjaro (tirzepatide). Lilly said ...
Regeneron has announced new results from the phase 2 COURAGE trial evaluating trevogrumab (anti-GDF8/anti-myostatin) for its ...
AbbVie has announced results from the ongoing phase 3 Viti-Up-1 and Viti-Up-2 studies of Rinvoq (upadacitinib; 15mg once ...
In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they ...
The annual awards recognise excellence across 15 categories spanning innovation, manufacturing, sustainability and leadership ...
Chiesi UK and Ireland has announced a new programme to help transform COPD diagnosis across the UK by providing NHS primary ...
NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment ...
AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square ...
Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, ...
Logistical challenges are not new in clinical research, from the high cost of developing new therapies to complexities in ...
The results for litifilimab support the potential to achieve rapid and durable improvements in skin disease activity ...
At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results